Suppr超能文献

使用莫达非尼成功治疗特发性嗜睡症和发作性睡病。

Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil.

作者信息

Bastuji H, Jouvet M

机构信息

Lab. Neurophysiologie Clinique, Hôpital Neurologique, Lyon, France.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(5):695-700. doi: 10.1016/0278-5846(88)90014-0.

Abstract
  1. Modafinil, a putative central alpha 1 adrenergic agonist, was tested in idiopathic hypersomnia and narcolepsy. 2. Sleep attacks and drowsiness were significantly decreased in 83% of 18 hypersomniac subjects and 71% of 24 narcoleptics. 3. When cataplectic episodes were not totally suppressed the association of a low dose of Clomipramine was successful in improving them. 4. Modafinil, used for at least 3 years in some patients, produces, in most cases, no peripheric sides effects, does not disturb night sleep and is never responsible of tolerance of drug dependence.
摘要
  1. 莫达非尼是一种假定的中枢α1肾上腺素能激动剂,已在发作性睡病和特发性嗜睡症中进行了测试。2. 18名嗜睡症患者中有83%以及24名发作性睡病患者中有71%的睡眠发作和嗜睡症状显著减轻。3. 当猝倒发作未被完全抑制时,联合低剂量氯米帕明可成功改善症状。4. 在一些患者中使用至少3年的莫达非尼,在大多数情况下不会产生外周副作用,不影响夜间睡眠,也不会导致药物耐受性或药物依赖。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验